Pinnacle Wealth Planning Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386K | Sell |
868
-218
| -20% | -$97.1K | 0.05% | 243 |
|
|
2025
Q1 | $527K | Buy |
1,086
+57
| +6% | +$27.6K | 0.08% | 160 |
|
|
2024
Q4 | $414K | Sell |
1,029
-74
| -7% | -$29.8K | 0.06% | 187 |
|
|
2024
Q3 | $513K | Hold |
1,103
| – | – | 0.07% | 191 |
|
|
2024
Q2 | $517K | Buy |
1,103
+1
| +0.1% | +$469 | 0.07% | 172 |
|
|
2024
Q1 | $461K | Sell |
1,102
-1
| -0.1% | -$418 | 0.07% | 203 |
|
|
2023
Q4 | $449K | Sell |
1,103
-1
| -0.1% | -$407 | 0.07% | 189 |
|
|
2023
Q3 | $384K | Sell |
1,104
-9
| -0.8% | -$3.13K | 0.06% | 204 |
|
|
2023
Q2 | $392K | Sell |
1,113
-1
| -0.1% | -$352 | 0.06% | 211 |
|
|
2023
Q1 | $351K | Buy |
1,114
+12
| +1% | +$3.78K | 0.06% | 240 |
|
|
2022
Q4 | $318K | Sell |
1,102
-116
| -10% | -$33.5K | 0.06% | 251 |
|
|
2022
Q3 | $353K | Sell |
1,218
-17
| -1% | -$4.93K | 0.07% | 197 |
|
|
2022
Q2 | $348K | Buy |
1,235
+258
| +26% | +$72.7K | 0.06% | 213 |
|
|
2022
Q1 | $255K | Sell |
977
-42
| -4% | -$11K | 0.05% | 306 |
|
|
2021
Q4 | $224K | Buy |
+1,019
| New | +$224K | 0.04% | 333 |
|
|
2021
Q2 | – | Sell |
-1,090
| Closed | -$235K | – | 369 |
|
|
2021
Q1 | $235K | Buy |
1,090
+137
| +14% | +$29.5K | 0.06% | 263 |
|
|
2020
Q4 | $225K | Buy |
953
+16
| +2% | +$3.78K | 0.05% | 253 |
|
|
2020
Q3 | $255K | Sell |
937
-7
| -0.7% | -$1.91K | 0.08% | 193 |
|
|
2020
Q2 | $274K | Sell |
944
-69
| -7% | -$20K | 0.09% | 171 |
|
|
2020
Q1 | $240K | Buy |
+1,013
| New | +$240K | 0.11% | 163 |
|